Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.825 USD | +9.91% | +29.73% | -10.33% |
May. 02 | CUREVAC : A missed opportunity | |
Apr. 26 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.33% | 779M | |
+32.73% | 50.85B | |
+1.07% | 42.82B | |
+49.34% | 42.03B | |
-4.22% | 29.55B | |
+10.97% | 26.11B | |
-21.61% | 19.13B | |
+9.12% | 13.05B | |
+27.48% | 12.16B | |
+23.77% | 12.08B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- Transcript : CureVac N.V., Q4 2023 Earnings Call, Apr 24, 2024